Daiichi Sankyo (OTCMKTS:DSNKY) Trading Down 0.1% – Should You Sell?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY)’s stock price was down 0.1% during mid-day trading on Thursday . The company traded as low as $23.62 and last traded at $23.82. Approximately 250,402 shares traded hands during mid-day trading, an increase of 21% from the average daily volume of 207,787 shares. The stock had previously closed at $23.85.

Analyst Upgrades and Downgrades

Separately, Nomura Securities upgraded shares of Daiichi Sankyo to a “strong-buy” rating in a research note on Friday, June 6th.

Daiichi Sankyo Stock Down 0.1%

The business’s 50 day moving average price is $24.68 and its 200-day moving average price is $25.49. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.53 and a quick ratio of 1.85. The company has a market cap of $45.12 billion and a P/E ratio of 23.13.

Daiichi Sankyo (OTCMKTS:DSNKY) last posted its earnings results on Friday, April 25th. The company reported $0.30 earnings per share (EPS) for the quarter. Daiichi Sankyo had a net margin of 15.65% and a return on equity of 17.92%. The company had revenue of $3.40 billion during the quarter. On average, analysts anticipate that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 0.73 earnings per share for the current fiscal year.

About Daiichi Sankyo

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.